| Univariate | Multivariate |
---|---|---|
Age (y) | 0.99 (0.95-1.03) | 0.99 (0.96-1.04) |
Lymph node ratio†| 1.08 (1.03-1.13)* | - |
Gender | Â | Â |
 Female | Reference | Reference |
 Male | 2.49 (0.69-9.06) | 1.16 (0.28-4.81) |
Location of tumor | Â | Â |
 Colon | Reference | - |
 Rectum | 1.06 (0.36-3.16) | - |
Depth of invasion | Â | Â |
 T1/T2 | Reference | Reference |
 T3 | 2.15 (0.46-10.12) | 3.9 (0.62-24.42) |
 T4 | 0.70 (0.12-4.17) | 0.76 (0.11-5.36) |
Stage | Â | Â |
 I | Reference | - |
 II | 0.81 (0.08-7.75) | - |
 III | 3.67 (0.47-29.00) | - |
Tumor grade | Â | Â |
 I | Reference | - |
 II | 0.93 (0.12-7.31) | - |
 III | 0.81 (0.07-9.03) | - |
Upstage | Â | Â |
 N0(i+) | 10.28 (1.44-73.34)* | 20.32 (2.09-197.98)* |
 N0 | Reference | Reference |
 N+ | 7.93 (1.71-36.83)* | 10.06 (2.04-49.58)* |
HE examination | Â | Â |
 Negative | Reference | - |
 Positive | 4.82 (1.48-15.70)* | - |
SLN examination | Â | Â |
 Negative | Reference | - |
 Positive | 1.50 (0.33-6.84) | - |